Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PEDIAMYCIN

ERYTHROMYCIN ETHYLSUCCINATE

Standard Dose
EQ 100MG BASE/2.5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PEDIAMYCIN is listed in Drugs@FDA under application 062305 (ANDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN ETHYLSUCCINATE Form and strength SUSPENSION/DROPS;ORAL - EQ 100MG BASE/2.5ML Sponsor ROSS LABS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview PEDIAMYCIN is listed in Drugs@FDA under application 062305 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN ETHYLSUCCINATE Form and strength SUSPENSION/DROPS;ORAL - EQ 100MG BASE/2.5ML Sponsor ROSS LABS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.